Alberta on track to administer 300,000 COVID-19 vaccines per week, premier says | FULL

About This Source - Global News

Global News is the news and current affairs division of the Canadian Global Television Network, based in Vancouver, Canada.

Recent from Global News:

  • Trudeau says Russia “more disruptive” than it has been in decades
  • Canada announces survivors, families of residential school victims to reclaim names | FULL
  • Whale of a tale: US diver survives nearly being swallowed by humpback whale
  • Global News published this video item, entitled “Alberta on track to administer 300,000 COVID-19 vaccines per week, premier says | FULL” – below is their description.

    Alberta Premier Jason Kenney said the province is now in a place where it can administer upwards of 300,000 doses of COVID-19 vaccine per week, if supply keeps up.

    Kenney made the announcement Monday morning, just over an hour before two new rapid flow-through vaccination sites opened in Calgary and Edmonton.

    The rapid vaccine sites at the Edmonton Expo Centre and Telus Convention Centre in Calgary were set to open at 12:30 p.m. by appointment only. Kenney said the sites will offer the Oxford-AstraZeneca vaccine to those aged 55 to 64.

    On Monday morning, Alberta began Phase 2C of its vaccine rollout plan, with more than 240,000 additional health-care workers now able to book their immunization appointment. This group includes nurses, doctors, dentists and any health-care workers in patient care facilities or those who provide direct patient care in the community.


    Subscribe to Global News Channel HERE:

    Like Global News on Facebook HERE:

    Follow Global News on Twitter HERE:

    Follow Global News on Instagram HERE:

    #GlobalNews #Alberta #COVID

    Global News YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: AstraZeneca

    AstraZeneca plc/AB (LON: AZN) is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, United Kingdom and Södertälje, Sweden. Its R&D is concentrated in Cambridge in United Kingdom, Södertälje in Sweden, and Maryland and Toronto in North America.

    3 Recent Items: AstraZeneca

  • Biden Says The End of the Global Pandemic Could Extend Past 2022
  • Coal mine evacuated amid flooding, PM pledges COVID-19 vaccines to other nations | 9 News Australia
  • Storm clean-up for Victoria, PM pledges to donate COVID vaccines to other nations | 9 News Australia
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Bongino says ‘evidence was everywhere’ for COVID lab leak theory
  • Berlin International Film Festival starts Summer Special
  • Malaysia extends COVID-19 lockdown until end of June
  • Hong Kong: Dragon Boat Festival held despite COVID restrictions
  • Novavax says its Covid vaccine is 90% effective in late stage trial
  • Leave a Comment